CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 327 enrolled
Drug / intervention
Epharmix/CareSignal eHealthdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03002311
NCT03002311N/ACompleted

Improving Medical Care With Electronic Interventions Based on Automated Text and Phone Messages

Washington University School of Medicine·interventional·Posted Dec 23, 2016·Updated Nov 24, 2020

In Brief

A clinical study evaluating Epharmix/CareSignal eHealth for General Medicine and 2 related conditions. Completed, enrolled 327 participants across 1 site.

Detailed Summary

This study's purpose is to test the effects of an electronic health intervention platform developed by Epharmix (also known as CareSignal), which features two-way SMS text messages and phone calls intended to improve clinical outcomes compared to the standard of care. This was a randomized open, blinded end-point (PROBE) trial of adult patients discharged from the ED and referred to a provider for follow-up care. Participants in the intervention arm received a self-scheduling text or phone message that automatically connected them to their referral provider to schedule a follow-up appointment and sent them appointment reminders. Those in the control arm received standard of care written instructions to contact listed referral providers. The primary outcome was time to the follow-up appointment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsEpharmix, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 23, 2016
Enrollment StartJan 1, 2016
Primary CompletionSep 18, 2017
Study CompletionMar 9, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.5 years ago

Interventions

Epharmix/CareSignal eHealthdevice

The self-scheduling text and phone messaging system was built by Epharmix/CareSignal. Participants in the intervention group began receiving text or voice messages (for landlines) starting 1 hour following ED discharge if during normal business hours, or at 1000 the next business morning. Automated messages were sent up to 3 days in a row or until the participant responded or opted out. The phone system would ultimately connect them directly to their referral provider or clinic to schedule an appointment. Once participants hung up with the referral clinic, the intervention texted or called back to solicit the appointment date. If a date was entered, the system sent reminders at 14 days, 7 days, 3 days, and 1 day before the appointment. After the appointment, the intervention texted or called participants to confirm if they attended.